Morphic therapeutics market cap
WebApr 14, 2024 · BioXcel Therapeutics Inc. (BTAI) current stock price is $19.14. During the last trading session, the stock soared, reaching $19.71 after opening at $16.89. The … WebMar 1, 2024 · WALTHAM, Mass., March 01, 2024 (GLOBE NEWSWIRE) -- Morphic Holding, Inc. (Nasdaq: MORF), a biopharmaceutical company developing a new generation of oral...
Morphic therapeutics market cap
Did you know?
WebApr 14, 2024 · Akero Therapeutics, Inc. ( NASDAQ:AKRO - Get Rating) - Lifesci Capital issued their Q1 2024 EPS estimates for Akero Therapeutics in a research report issued to clients and investors on Tuesday, April 11th. Lifesci Capital analyst P. Dolezal anticipates that the company will earn ($0.58) per share for the quarter. WebAs of April 2024 Morphic Therapeutic has a market cap of $1.48 Billion. This makes Morphic Therapeutic the world's 4142th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total …
WebOperating Margin for Morphic Therapeutic (MORF) Operating Margin as of February 2024 (TTM): -78.62%. According to Morphic Therapeutic's latest financial reports and stock … WebMorphic Therapeutic is leading the development of a new generation of oral integrin drugs. Drawing on discoveries made in the lab of Scientific Founder Tim Springer, Morphic is advancing preclinical programs in autoimmunity, fibrosis, vascular disorders and immuno-oncology. Morphic was created in 2015 with support from Leukon Investment, Polaris …
WebApr 6, 2024 · Morphic Holding, Inc. is a biopharmaceutical company. The Company is engaged in discovering and developing a pipeline of oral small molecule integrin therapeutics for the treatment of serious chronic diseases, including autoi mmune, cardiovascular and metabolic diseases, fibrosis and cancer. The Company's Morphic … Web1 hour ago · In a report released today, Gregory Renza from RBC Capital reiterated a Buy rating on Nurix Therapeutics ( NRIX – Research Report ), with a price target of $30.00. The company’s shares opened ...
WebMar 6, 2024 · RBC Capital Markets Healthcare Conference Fireside Chat. May 18, 2024 at 1:55 PM EDT 41st Annual Cowen Health Care Conference. Mar 2, 2024 at 11:10 AM EST Morphic Financial and Operational Results 2024 Year End Conference Call. Mar 1, 2024 at 8: ... ©2024 Morphic Therapeutics, Inc.
WebMorphic Therapeutic (NASDAQ: MORF) develops oral integrin therapies for immunological, fibrotic, neoplastic and vascular diseases. Use the CB Insights Platform to explore Morphic Therapeutic's full profile. ... Market Cap 1.65B. Stock Price 41.82. About Morphic Therapeutic. オクラ 固い 見分け方WebApr 9, 2024 · Also, the market prices HRMY at a forward multiple of 14.69. As a discount to earnings, Harmony ranks better than 79.66% of other biotech stocks to buy. Lastly, covering analysts peg HRMY as a ... オクラ 和え物 豆腐WebJun 26, 2024 · WALTHAM, Mass.--(BUSINESS WIRE)--Jun. 26, 2024-- Morphic Holding, Inc. (“ Morphic ”), a biopharmaceutical company discovering and developing oral small … オクラ 塩もみ しないWebMar 3, 2024 · WALTHAM, Mass., March 02, 2024 (GLOBE NEWSWIRE) -- Morphic Holding, Inc. (Nasdaq: MORF), a biopharmaceutical company developing a new generation of oral integrin therapies for the treatment of serious chronic diseases, today announced the pricing of an upsized underwritten public offering of 3,500,000 shares of its common … pappagallo in inglese traduzioneWebn/a. Market Cap. S$65.09m. GDTC key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA. Key Statistics. Enterprise … オクラ 唐揚げ バズレシピWebMorphic Holding Inc is a biopharmaceutical company applying its insights into integrins to discover and develop a pipeline of oral small-molecule integrin therapeutics. Integrins … pappagallo inseparabile costoWebMar 16, 2024 · Stock price history for Morphic Therapeutic (MORF) Highest end of day price: $84.85 USD on 2024-03-01. Lowest end of day price: $10.84 USD on 2024-03-16. … おくら 塩